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INTRODUCTION
Angiosarcoma (AS) of breast is a rare malignancy,
accounting for only about 0.05% of all the primary malig-
nancies. These are divided into two main categories
depending on origin i.e. primarily in breast as primary
angiosarcoma and after radiation therapy as cutaneous
angiosarcomas.1
Angiosarcomas arising in association with radiotherapy
are a well-established iatrogenic phenomena mainly
involving the skin, while the primary angiosarcomas
arise within breast parenchyma. Only 11 angiosarcomas
were identified among more than 5000 malignant breast
neoplasms (0.1 – 0.2% incidence) for the last 10 years.
Eight cases (6 high grade, 1 intermediate grade, 1 low
grade) were identified as post-radiation angiosarcoma
(post-radiation time interval, 4 – 12 years), and 3 cases
were identified as primary angiosarcomas (1 high grade,
2 low grade).3,4 The mainstay of treatment is surgical
resection followed by chemotherapy and radiotherapy if
margins of excision are close.
CASE REPORT
Case 1: A 32 years old woman, presented to Breast
OPD in September 2010, with complaints of right breast
lump for past 2 weeks. On physical examination, the
lump was at 9 O’clock position, soft to firm in
consistency. On mammography, it was reported as
solitary ill-defined mass, with size of 1 x 0.8 cms,
BIRADS-IV, probably malignant and needle localization
biopsy was recommended. On ultrasonography (USG),
it was a hypoechoiec solid mass. Wide local excision
was done. On gross examination, it was small lesion,
black and histological examination with immuno-
histochemical staining (CD 31, CD 34 and Factor-VIII)
revealed low-grade angiosarcoma. One of the excision
margins was close. Patient received 6 cycles of
radiotherapy. On one and half year follow-up, the patient
was without any complications of treatment. No
metastasis or recurrence was present.
Case 2: A 54 years old woman with a 5 months history
of discoloured painless enlargement of left breast came
to Breast OPD in April 2009. On her USG examination,
it was of heterogeneous echogenecity with hyperechoeic
foci without acoustic shadowing. On mammography, it
was poorly defined, lobulated mass without spiculations
or calcification, 8.5 x 6.2 cms in size and BIRADS-V. On
physical examination, it was a non-tender firm mass.
Trucut biopsy was reported as spindle cell neoplasm
with the differential diagnosis of sarcoma and
phyllodes tumour. The surgeon proceeded with simple
mastectomy. On gross examination, it was firm,
haemorrhagic, blackish lesion measuring 6.5 x 6 x 6
cms. Few areas of necrosis were visible to naked eye
examination.
Microscopic examination showed anastomosing stag-
horn vascular channels lined by malignant cells present
in form of fascicles, sheets and papillary formation
focally, portion of nucleus was bulging into the lumen
giving it hobnail appearance (Figures 1 and 2).
Tumours were histologically graded using Rosen's 3-tier
system into low (I), intermediate (II) and high (III) grades. 
Patient did not receive post-surgery radio or chemo-
therapy. She gave follow-up visits for one year, during
which she did not develop recurrence or metastasis. She
was then lost to follow-up.
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DISCUSSION
Angiosarcomas are aggressive tumours of endovascular
origin. There are no distinct clinical or histologic
differences between primary and post-radiation breast
angiosarcomas.3 Although angiosarcomas are relatively
rare, they are being reported with increasing frequency
in patients who have previously undergone breast
conserving therapy and the histologic and cytological
appearance can be highly suggestive of recurrent breast
carcinoma.5
Primary angiosarcomas of the breast occur sporadically
in young women and usually present as palpable
masses. Three grades of angiosarcoma are described.
Low-grade tumours consist of anastomosing vascular
channels that invade the surrounding breast tissue.
Intermediate-grade tumours have more solid neoplastic
vascular growth and an increased mitotic rate. High-
grade lesions have frankly sarcomatous areas, as well
as areas of necrosis, haemorrhage, and infarction.
Complete excision and careful histologic evaluation are
needed to accurately determine the tumour grade.
Bluish skin discolouration occurs in upto a third of
patients and is thought to be attributable to the vascular
nature of the tumour.6
Primary lesions arise in younger women, usually during
the third and fourth decades of life; these lesions are
unlike breast carcinomas, which typically arise later in
life. Although angiosarcoma has been reported to
present during pregnancy, no evidence supports the
hypothesis that these tumours are hormone-dependent.
Vascular proliferations of the breast are uncommon but
potentially diagnostically challenging lesions as a range
of benign entities which must be differentiated from
angiosarcoma also exists.6
Primary angiosarcomas typically occurs in pre-
menopausal women with mean age of 35 years i.e. a
younger age, in general, than primary breast carcinoma.
The imaging features on mammography are often non-
specific and between 19% and 33% of lesions are un-
detectable by mammography.
Macroscopically, primary AS in the breast ranges from
10 to 200 mm in diameter, with an average size of
40 – 55 mm. Low-grade lesions are characterized by
proliferation of well-formed, anastomosing vascular
channels that diffusely infiltrate both glandular
parenchyma of the breast and fat. Mitotic figures are
rare. The vascular spaces are usually closely packed
with minimal intervening stroma, although occasional
cases may have a collagenous stroma. Low-grade
variants lesions composed predominantly of small
vessels that can resemble a haemangioma, or PASH
(Pseudoangiomatous Stromal Hyperplasia) like stromal
infiltration, narrow vascular channels without an obvious
anastomosing architecture or a primarily spindle cell
infiltration within fat that may simulate an angiolipoma on
limited sampling.
Intermediate-grade AS resembles low-grade lesions, but
commonly, the cellular areas may suggest Kaposi's
sarcoma. High-grade AS has overtly sarcomatous
areas.1 The main differential diagnoses of high-grade AS
are metaplastic carcinoma with angiosarcomatous
differentiation and other poorly differentiated sarcomas.
Histologically, the presence of characteristic low-grade
AS at the periphery of the lesion can be helpful in
diagnosis. Similarly, metaplastic carcinomas may be
associated with DCIS or areas of typical invasive
carcinoma. In more difficult cases, immunohisto-
chemistry for vascular markers and cytokeratin may be
invaluable. More than 90% of cases of AS are
immunopositive for CD31, CD34 and Factor-VIII. CD31
is the most specific marker for endothelial differentiation,
whereas CD34 is more sensitive, but also stains other
lesions, such as phyllodes tumour and PASH which is
a mesenchymal lesion which may produce a mass
Figure 1: High grade primary angiosarcoma; Tumour cells with cytology of
plump hyperchromatic, tufted endothelial cells having scant amphophilic
cytoplasm. Arrows point at mitotic figures (Hematoxylin-eosin, original
magnification x 40).
Figure 2: Breast angiosarcoma - anatomopathological diagnosis. Immuno-
histochemical positive stain for CD 31. (Original magnification x 40).
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clinically. So it comes in close differential of well
differentiated angiosarcoma both clinically and micro-
scopically.
Primary AS is an aggressive neoplasm with a tendency
to local recurrence and distant metastasis. The
commonest sites of metastasis are bone, lung, liver,
brain, ovary and skin. The contralateral breast is also a
common site of metastasis, occurring in approximately
21% of cases. Lymph node involvement is present in
only 6 – 8% of cases. Histological progression in
recurrences from low to high-grade lesions is well
described.7 The prognosis of primary AS of the breast is
thus generally poor, with 70% of patients dying. Rosen
et al. have demonstrated that tumour grade is the most
important predictor of recurrence. Complete local
excision with histologically clear margins is the basis of
management.8 Wide local excision may be considered
for the rare small lesions identified. Rosen et al. have
demonstrated that tumour grade is the most important
predictor of recurrence. The estimated probability of
disease-free survival 5 years after initial treatment is
76% for patients with grade-1 tumours; for patients with
grade-3 tumours, the probability is 15%.6
Spindle cell lesions of the breast represent an interest-
ing diagnostic problem, as the differential diagnoses
are wide.9 Diagnosing this is particularly problematic
but important as treatments of different entities are
different.
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